HIPRA Logo General Public site

Welcome to the Malta BIMERVAX® COVID-19 Vaccine website.

This website is not intended for members of the general public.

Please confirm that you are a Healthcare Professional or Other Relevant Decision Maker in Malta.

I am not a Healthcare Professional

Disclaimer: This page is intended for Healthcare Professionals and other relevant decision makers in Malta only.

Information about the BIMERVAX® COVID-19 Vaccine.

Marketing authorisation for Malta has been granted by the European Medicines Agency to be used for individuals 16 years of age and older.

Summary of Product Characteristics (SmPC) (PDF)
Download PDF
Package Leaflet (PDF)
Download PDF
Vaccination Card
Download PDF

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system.

Company information

Avinguda la Selva, 135
17170 Amer (Girona)
Spain
© 2023 HIPRA.